Role of H2S Donors in Cancer Biology

Zheng-Wei Lee1, Lih-Wen Deng

  • 1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117596, Singapore.

Insights

Hydrogen sulfide (H2S) donors show promise in cancer research by suppressing tumor growth and metastasis. Further investigation is needed to identify molecular targets for therapeutic applications.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Hydrogen sulfide (H2S) and its donors are valuable tools for investigating cancer biology.
  • Studies indicate H2S can suppress tumor growth in vitro and in vivo, with selective cytotoxicity towards cancer cells.

Purpose of the Study:

  • To review the anticancer effects of H2S donors.
  • To explore the mechanisms underlying H2S's anticancer activities.
  • To highlight the therapeutic potential and challenges of H2S in cancer treatment.

Main Methods:

  • Review of existing studies on H2S donors in cancer research.
  • Analysis of mechanisms including cell signaling, cell cycle, microRNAs, and metabolism.
  • Evaluation of in vitro and in vivo data on tumor suppression, angiogenesis, and metastasis.

Main Results:

  • H2S donors demonstrate significant suppression of tumor growth, angiogenesis, and metastasis.
  • Anticancer effects are mediated through modulation of MAPK, STAT signaling, cell cycle, microRNAs, and cancer metabolism/pH.
  • Evidence suggests selective cytotoxicity of H2S towards cancer cells.

Conclusions:

  • H2S donors exhibit considerable potential as anticancer agents.
  • Mechanisms involve diverse cellular pathways crucial for cancer progression.
  • Further research is required to identify specific molecular targets for H2S-based therapies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K